Background A declining cognitive performance is a hallmark of Huntington's disease (HD).
The neuropsychological battery of the Unified HD Rating Scale (UHDRS'99) is commonly …

Background Clinician-rated measures of functioning are often used as primary endpoints in
clinical trials and other behavioral research in Huntington disease. As study costs for …

Background Progressive cognitive decline is an inevitable feature of Huntington's disease
(HD) but specific criteria and instruments are still insufficiently developed to reliably classify …

Objective Cognitive decline is a key characteristic of Huntington's disease (HD). This study
aimed to investigate the diagnostic accuracy of a cognitive battery with six tests used by …

Objective: Huntington's disease (HD) is an inherited movement disorder characterized by
choreiform movements and frontostriatal dysfunction. Previous studies have documented …

Progressive cognitive decline is a feature of Huntington's disease (HD), an inherited
neurodegenerative movement disorder. Comprehensive neuropsychological testing is the …

Abstract Purpose Individuals with Huntington disease (HD) experience progressive
cognitive decline that may appear years before motor manifestations of the disease. These …

Abstract Purpose Symptom progression in Huntington disease (HD) is associated with
cognitive decline which may interfere with the self-report of symptoms. Unfortunately, data to …

Background Prior to clinical diagnosis, individuals with the CAG expansion for Huntington's
disease demonstrate subtle impairment on a number of neurocognitive tests relative to …

Abstract Background Patients with Huntington's disease (HD) exhibit a variable
predominance of cognitive, behavioral and motor symptoms. A specific instrument focusing …